Studienambulanz Rheumazentrum Ratingen GbR — Clinical Trial Site

14 Registered trials

8 Currently recruiting

Organisation

Studienambulanz Rheumazentrum Ratingen GbR

Location

Ratingen, Germany

Identifier

ORG-100051526

Address

Calor-Emag-Strasse 3, Zentrum, 40878, Germany

Departments

#302
#40800;
1. Medizinische Klinik
2052:N/A
N/A
NA
Rheumazentrum
Rheumazentrum Ratingen
Rheumazentrum Ratingen Studienambulanz
Rheumazentrum Ratingen; Rheumaforschung - Studienambulanz
Studienambulanz

Clinical trials at this site (14)

Search interface

A Phase 3, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Subjects with Active Pso… Pending

2025-522586-30-00 Psoriatic Arthritis 5
A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults Recruiting

2025-522782-30-00 CCI 3 2026-04-07
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or… Recruiting

2025-521034-28-00 Moderate to Severe Rheumatoid Arthritis (RA) 4 2025-12-05
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 3 Protocol to Assess the Efficacy and Safety of Nipocalimab in Adults with… Recruiting

2024-513965-38-01 Sjögren's Disease 5 2025-06-16
A randomized, two-period crossover study to demonstrate the comparability of pharmacokinetics of subcutaneous ianalumab between 2mL auto-inj… Recruiting

2023-508996-35-00 Rheumatoid Arthritis 4 2024-11-18
A clinical study of tulisokibart to treat radiographic axial spondyloarthritis (MK-7240-013) Recruiting

2025-521059-21-00 Radiographic axial spondyloarthritis (as known as ankyl 4 2025-11-25
A clinical study of tulisokibart in people with rheumatoid arthritis (MK-7240-014) Recruiting

2025-521745-25-00 Rheumatoid Arthritis 4 2025-11-06
A Study of Zasocitinib in Adults with Psoriatic Arthritis Who Have Not Taken Biologic Medicines Recruiting

2024-513111-27-00 Psoriatic Arthritis 5 2025-06-26
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-experienced Participants with Active Psoriatic Arthritis Recruiting

2024-517284-23-00 Active Psoriatic Arthritis 5 2025-04-23
Proof of Concept trial with CIT-013 in Rheumatoid Arthritis Ended

2024-517356-35-00 Moderately Active Rheumatoid Arthritis 4 2025-07-29
A Phase 2b to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With ACPA-Positive Rheumatoid Arthritis Ended

2024-515973-82-00 ACPA-Positive Rheumatoid Arthritis 4 2025-06-23
A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended

2024-511738-11-00 Psoriatic arthritis 5 2024-12-18
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Ended

2024-512554-15-00 COVID-19 5 2023-06-21
A Multicenter, Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis Ended

2024-513919-27-00 Rheumatoid arthritis 5 2017-09-14